News

Check out market updates

Brickell buys drug prospect, adds new CMO

BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) has acquired a clinical-stage drug candidate and added a chief medical officer to […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *

X